Composition for preventing, alleviating or treating respiratory diseases

The invention relates to a novel compound and application thereof. The novel compound according to the present invention induces activation of MKP-1 protein to block a cellular signaling pathway performed in the p38/CK2 alpha/NF-kappa B order, thereby very effectively inhibiting inflammatory respons...

Full description

Saved in:
Bibliographic Details
Main Authors LEE HEON-KU, IM SUN-YOUNG, SONG HELING, GI BEOM HONG, LEE JU-SUEK, LEE JI-HOON, YOO JI HOON, HAN MYUNG-KWAN
Format Patent
LanguageChinese
English
Published 15.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a novel compound and application thereof. The novel compound according to the present invention induces activation of MKP-1 protein to block a cellular signaling pathway performed in the p38/CK2 alpha/NF-kappa B order, thereby very effectively inhibiting inflammatory responses occurring in respiratory diseases. Accordingly, respiratory diseases can be prevented, relieved or treated by oral administration of the novel compound according to the present invention. 本发明涉及一种新颖的化合物及其用途。根据本发明的新颖的化合物诱导MKP-1蛋白的活化来阻断以p38/CK2α/NF-κB顺序进行的细胞信号传导通路,从而非常有效地抑制呼吸系统疾病中发生的炎症反应。因此,可以通过口服施用根据本发明的新颖的化合物来预防、缓解或治疗呼吸系统疾病。
Bibliography:Application Number: CN202080082256